MINNEAPOLIS, June 03, 2026 (GLOBE NEWSWIRE) -- Celcuity Inc. (Nasdaq: CELC) (“Celcuity” or the “Company”), a clinical-stage biotechnology company focused on the development of targeted therapies for the treatment of multiple solid tumor indications, today announced the pricing of its upsized underwritten public offering of $500,000,000 aggregate principal amount of its 0.250% convertible senior notes due 2032 (the “Convertible Notes”). The aggregate principal amount of the offering was increased from the previously announced offering size of $400,000,000.
With Category A COE prices exceeding S$100,000, GetGo stages a car smash to make the case for sustainable, commitment-free access to driving.SINGAPORE, June 4,...
REDWOOD CITY, Calif., June 3, 2026 /PRNewswire/ -- Liftoff Mobile, Inc. ("Liftoff"), a global leader in performance marketing and monetization solutions for the app...
BEIJING, June 3, 2026 /PRNewswire/ -- Jianzhi Education Technology Group Company Limited (NASDAQ: JZ) (the "Company" or "Jianzhi") today announced the closing of its...
The article breaks down pricing factors and helps readers understand what influences hearing aid expenses.SOUTHLAKE, Texas, June 3, 2026 /PRNewswire/ -- What should residents...
BUFFALO, N.Y., June 3, 2026 /PRNewswire/ -- What does homeowners insurance really protect, and how can homeowners avoid costly surprises? That question is answered...
BEIJING, China, June 03, 2026 (GLOBE NEWSWIRE) -- Zhihu Inc. (“Zhihu” or the “Company”) (NYSE: ZH; HKEX: 2390), a leading online content community in China, today announced its unaudited financial results for the quarter ended March 31, 2026.
NEW YORK, June 02, 2026 (GLOBE NEWSWIRE) -- Figure Technology Solutions (Nasdaq: FIGR; OPEN: FGRS), the leading blockchain-native capital marketplace for the origination, funding, sale, and trading of tokenized assets, today reported select preliminary operating data for the month ended May 31, 2026.